8-K
filed May 9, 2024, 7:59 PM ET
ticker VCNX
CIK 0001205922
other material
confidence high
sentiment neutral
materiality 0.15
Vaccinex shareholders elect directors, approve say-on-pay and incentive plan amendment
VACCINEX, INC.
- Elected Jacob Frieberg, Albert Friedberg, and Maurice Zauderer as directors with >425k votes each.
- Advisory say-on-pay passed with 521,607 votes for vs 27,555 against.
- Shareholders chose annual frequency for future say-on-pay votes (539,907 for 1 year).
- First amendment to 2018 Omnibus Incentive Plan approved 403,835 for, 146,143 against.
- Ratified Deloitte & Touche as auditor for FY2024 with 674,404 votes for.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
VACCINEX, INC. shareholders approved Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2024 at the 2024-05-09 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2024-05-09
Exact text from the filing
Proposal 5. The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. Votes For Votes Against Votes Abstained 674,404 8,972 417
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
VACCINEX, INC. shareholders approved Approval of First Amendment to the Vaccinex, Inc. 2018 Omnibus Incentive Plan at the 2024-05-09 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2024-05-09
Exact text from the filing
Proposal 4. The Company’s stockholders approved the First Amendment to the Vaccinex, Inc. 2018 Omnibus Incentive Plan. Votes For Votes Against Votes Abstained Broker Non-Votes 403,835 146,143 308 133,507
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
VACCINEX, INC. shareholders approved Election of three directors for three-year terms expiring in 2027 at the 2024-05-09 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2024-05-09
Exact text from the filing
Proposal 1. The Company’s stockholders elected the following nominees as directors, each to serve for a three-year term expiring in 2027. Director Nominee Votes For Authority Withheld Broker Non-Votes Jacob Frieberg 425,443 124,843 133,507 Albert Friedberg 425,131 124,155 133,507 Maurice Zauderer 425,477 124,809 133,507
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
VACCINEX, INC. shareholders approved Non-binding advisory vote on compensation of named executive officers at the 2024-05-09 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2024-05-09
Exact text from the filing
Proposal 2. The Company’s stockholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers. Votes For Votes Against Votes Abstained Broker Non-Votes 521,607 27,555 1,124 133,507
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
VACCINEX, INC. shareholders approved Advisory vote on frequency of future say-on-pay votes (every year, 2 years, or 3 years) at the 2024-05-09 meeting.
- Proposal
- say on pay frequency
- Outcome
- passed
- Meeting
- 2024-05-09
Exact text from the filing
Proposal 3. The Company’s stockholders determined, on a non-binding advisory basis, that future advisory votes on the compensation of the Company’s named executive officers shall be held every year. Votes For 1 Year Votes For 2 Years Votes For 3 Years Votes Abstained 539,907 1,950 7,045 1,384
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.